Acanthamoeba keratitis is a rare but blinding parasitic eye disease. Experts share how to avoid it and treat it.
Check out our weekly list of new fundraisers from Lend A Hand Up, a nonprofit crowdfunding site supporting families in Cass, ...
VIVIAN Nosovitsky lost vision in her right eye after it was “eaten away” by a parasite she caught “on the bus”. The ...
The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness. Akantior ...
Bengaluru-based clinical-stage regenerative medicine player Pandorum Technologies has entered into a strategic collaboration ...
Kolkata: Scientists from the Bose Institute, Kolkata, and the LV Prasad Eye Institute, Hyderabad, identified a novel ...
Contact lens hygiene knowledge and compliance is high — as is awareness of microbial keratitis — but stronger among women than men.
Background On 14 August 2024, the WHO redesignated Monkeypox (mpox) as a Public Health Emergency of International Concern.
Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...
Like any medication, Dupixent may cause various side effects. It’s especially known to cause side effects relating to the eyes, such as conjunctivitis, blepharitis, and keratitis. These side effects ...
Investor call and webcast to be held July 9 at 8:30 am ET to discuss program and trial design PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) ...
Krystal Biotech, Inc. announced the dosing of the first patient in its Phase 1/2 clinical trial, EMERALD-1, which is evaluating KB801, an eye drop gene therapy for neurotrophic keratitis (NK), a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results